Middle East and Africa Cell Therapy Market

Market Introduction

Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.

Market Dynamics

The Middle East and Africa cell therapy market is expected to reach US$ 346.7 million by 2027 from US$ 234.4 million in 2019; it is anticipated to grow at a CAGR of 5.1% during 2019–2027. Factors such as increasing prevalence of chronic diseases, rising adoption of regenerative medicines and increasing number of approvals for cell-based therapies are expected to boost the growth of the cell therapy market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of cell therapy manufacturing, during the forecast period.

COVID-19 pandemic has become the most significant challenge across the Middle East and Africa region. Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. Therefore, countries have faced several challenges for their requirements. Initial phase of lockdown in various countries has affected the supply of many instruments in these regions. Therefore, many organizations are collaborating with others to overcome this pandemic by using cell therapies for the treatment of COVID 19. For instance, United Arab Emirates-based Abu Dhabi Stem Cells Center (ADSCC) has entered into collaboration agreement with Pluristem Therapeutics Inc. to develop cell therapies and regenerative medicines for the treatment of COVID-19.

Market Scope

The scope of the Middle East and Africa cell therapy market includes therapy type, product, technology, applications, end user and countries. In terms of therapy type, the allogeneic segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019. In terms of product, the consumables segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019. The viral vector technology segment accounted for the largest share of the Middle East and Africa cell therapy market, by technology, in 2019. In terms of applications, the Oncology segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019. In terms of end user, the Research Institutes segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the Middle East and Africa cell therapy market report are the World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), National Institute of Health of South Africa, and Department of Health Abu Dhabi, Abu Dhabi Stem Cell Center (ADSCC)  and among others.  

Reasons to Buy Report

• It provides understanding of the Middle East and Africa, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.
• It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa cell therapy market.
• It helps efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
• It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the Middle East and Africa cell therapy market.
• It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.

MIDDLE EAST AND AFRICA CELL THERAPY MARKET SEGMENTATION

By Therapy Type

• Allogeneic
• Autologous

By Product

• Consumables
• Equipment
• Systems and Software

By Technology

• Viral Vector Technology
• Genome Editing Technology
• Somatic Cell Technology
• Cell Immortalization Technology
• Cell Plasticity Technology
• Three-dimensional Technology

By Application

• Oncology
• Cardiovascular
• Orthopedic
• Wound Management
• Other Applications

By End User

• Research Institutes
• Hospitals
• Others

By Country

• Saudi Arabia
• UAE
• South Africa

Company Profiles

• NuVasive, Inc.
• Smith & Nephew
• Bristol-Myers Squibb Company

Middle East and Africa Cell Therapy Market Strategic Insights

Middle East and Africa Cell Therapy Market Segmentation Analysis

Middle East and Africa Cell Therapy Market Report Highlights

Middle East and Africa Cell Therapy Report Scope

Middle East and Africa Cell Therapy Market Country and Regional Insights